
A Prospective, Open Label, Randomized Phase II Trial of Weekly Docetaxel Versus Weekly Vinorelbine as First Line Chemotherapy in Patients With Androgen Independent Prostate Cancer
Keywords: prostatic neoplasms; drug therapy; docetaxel; vinorelbine; AIPC; androgen independent prostate cancer; CT; computerized tomography; EMP; estramustine phosphate; PSA; prostate specific antigen; TTP; time to progression;